ALVOW
Alvotech WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.25
52W High
$2.98
52W Low
$0.15
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
4.74%
Forward P/E
—
PEG Ratio
—
About Alvotech Warrant
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
Fundamentals
| Revenue (TTM) | $588.90M |
| Gross Profit (TTM) | $355.55M |
| EBITDA | $115.76M |
| Operating Margin | 30.90% |
| Return on Equity | 0.00% |
| Return on Assets | 3.60% |
| Revenue/Share (TTM) | $2.11 |
| Book Value | $-0.91 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -58.40% |
| Quarterly Revenue Growth (YoY) | 10.10% |
| Shares Outstanding | 0 |
| Float | $114.08M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/7/2026